DURATION-8 Randomized Controlled Trial 104-Week Results—Once-Weekly Exenatide (ExQW) plus Once-Daily Dapagliflozin (DAPA) vs. ExQW or DAPA Alone

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 104-LB ◽  
Author(s):  
SERGE JABBOUR ◽  
CRISTIAN GUJA ◽  
ELISE HARDY ◽  
SUDIPTA BHATTACHARYA ◽  
PETER K. OHMAN ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document